WQ1.F MEDAPP S.A. ZY -10
- Market cap
- EUR 4.95M
- P/E
- -
- P/B
- 2.02x
- ROE
- 18.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is WQ1.F undervalued?
Graham numberThe Graham number of MEDAPP S.A. ZY -10 cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MEDAPP S.A. ZY -10 fundamental analysis
No fundamental analysis for MEDAPP S.A. ZY -10 yet.
MEDAPP S.A. ZY -10 stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About MEDAPP S.A. ZY -10
MedApp S.A. engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife Holo, a technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. HoloComm, an innovative solution for easy and convenient work on files in 3D. The company was formerly known as Yellow Hat S.A. and changed its name to MedA…
Full company profileMEDAPP S.A. ZY -10 financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
MEDAPP S.A. ZY -10 annual financial statements (PLN; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 12.7M | 6.73M | 5.74M | 7.20M | 3.82M | 12.0M |
| Gross Profit | 10.9M | 5.23M | 4.14M | 5.36M | 1.26M | 5.64M |
| Operating Income | 5.59M | 1.13M | 328K | 1.84M | -1.16M | 3.27M |
| EBITDA | - | 3.00M | 2.18M | 3.41M | -317K | 3.36M |
| Net Income | 4.12M | 609K | -3.13M | 1.63M | -2.71M | 3.13M |
| EPS | 0.02 | 0.00 | -0.01 | 0.01 | -0.01 | 0.01 |
| Balance Sheet | ||||||
| Total Assets | 32.5M | 32.1M | 35.7M | 32.1M | 31.5M | 33.5M |
| Total Liabilities | 7.23M | 4.95M | 8.99M | 11.6M | 13.6M | 14.0M |
| Shareholders' Equity | 25.2M | 27.2M | 24.0M | 17.7M | 15.0M | 16.6M |
| Cash & Short-term Investments | 131K | 42.0K | 215K | 122K | 245K | 1.18M |
| Cash Flow | ||||||
| Operating Cash Flow | -437K | 5.72M | -1.33M | 4.17M | 2.56M | 1.40M |
| Capital Expenditure | 240K | 6.52M | 0.00 | 3.48M | 1.81M | 192K |
| Free Cash Flow | -677K | -795K | -1.33M | 685K | 749K | 1.20M |
| Ratios | ||||||
| ROE | 16.3% | 2.2% | -13.0% | 9.2% | -18.0% | 18.9% |
| ROA | 12.7% | 1.9% | -8.8% | 5.1% | -8.6% | 9.3% |
| Net Profit Margin | 32.4% | 9.0% | -54.5% | 22.6% | -71.0% | 26.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
MEDAPP S.A. ZY -10 dividends
MEDAPP S.A. ZY -10 has not paid dividends in the last 6 fiscal years.
Who owns MEDAPP S.A. ZY -10
- Insiders 51.81%
- Institutions 0.00%
- Public & others 48.19%
- Shares outstanding 250M
- Free float 121M
MEDAPP S.A. ZY -10 company profile
- Company name
- MEDAPP S.A. ZY -10
- Ticker
- WQ1.F
- ISIN
- PLYLWHT00012
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 15
- Fiscal year end
- December
- Address
- Aleja Juliusza Slowackiego 6/10, Kraków, Poland, 30-037
- Phone
- 48 53 330 6117
- Website
- medapp.pl
About MEDAPP S.A. ZY -10
MedApp S.A. engages in the development of solutions to support imaging diagnostics and digital medicine in Poland, rest of the European Union, and internationally. The company offers CarnaLife Holo, a technology for 3D visualization of imaged medical data which supports the planning and performance of medical procedures. HoloComm, an innovative solution for easy and convenient work on files in 3D. The company was formerly known as Yellow Hat S.A. and changed its name to MedApp S.A. in February 2016. The company was incorporated in 2010 and is headquartered in Kraków, Poland. MedApp S.A. is a subsidiary of Doktor Guzik Fundacja Rodzinna W Organizacji.
MEDAPP S.A. ZY -10 management
1- Mr. David OdrakiewiczChairman of Management Board